Clarification from Russian expert organization regarding telmisartan BE studies [Regulatives / Guidelines]

posted by Beholder  – Russia, 2019-11-08 06:51 (590 d 05:34 ago) – Posting: # 20764
Views: 4,380

(edited by Beholder on 2019-11-08 10:27)

Hi to all!

An article which might serve as "guideline" for conducting telmisartan BE studies in Russia written by expert organization representative. Open access and abstract in English is available.

Main points represented in the article:
  1. 7 BE studies performed in Russia were assessed.
  2. Not only males should be enrolled but females as well (50/50).
  3. HPLC FLD is, in some cases, more sensitive than HPLC MS/MS (see study 3) ;-).

Best regards

Complete thread:

 Admin contact
21,530 posts in 4,499 threads, 1,523 registered users;
online 17 (0 registered, 17 guests [including 2 identified bots]).
Forum time: Sunday 12:25 UTC (Europe/Vienna)

Intellect distinguishes between the possible and the impossible;
reason distinguishes between the sensible and the senseless.
Even the possible can be senseless.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz